Long	B-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	E-ENHANCER
modulate	O
Foxf1	O
transcription	O
in	O
blood	O
vessels	O
of	O
pulmonary	O
vascular	O
network	O
.	O


Intimate	O
crosstalk	O
occurs	O
between	O
the	O
pulmonary	O
epithelium	O
and	O
the	O
vascular	O
network	O
during	O
lung	O
development	O
.	O


The	O
transcription	O
factor	O
forkhead	O
box	O
f1	O
(	O
Foxf1	O
)	O
is	O
expressed	O
in	O
the	O
lung	O
mesenchyme	O
and	O
plays	O
an	O
indispensable	O
role	O
in	O
pulmonary	O
angiogenesis	O
.	O


Sonic	O
hedgehog	O
(	O
Shh	O
)	O
,	O
a	O
signalling	O
molecule	O
,	O
is	O
expressed	O
in	O
lung	O
epithelium	O
and	O
is	O
required	O
to	O
establish	O
proper	O
angiogenesis	O
.	O


It	O
has	O
been	O
suggested	O
that	O
Foxf1	O
,	O
a	O
downstream	O
target	O
of	O
the	O
Shh	O
signalling	O
pathway	O
,	O
mediates	O
interaction	O
between	O
angiogenesis	O
and	O
the	O
epithelium	O
in	O
lung	O
.	O


However	O
,	O
there	O
has	O
been	O
no	O
clear	O
evidence	O
showing	O
the	O
mechanism	O
how	O
Foxf1	O
is	O
regulated	O
by	O
Shh	O
signalling	O
pathway	O
during	O
lung	O
development	O
.	O


In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
lung	B-ENHANCER
-	I-ENHANCER
specific	I-ENHANCER
enhancers	I-ENHANCER
of	I-ENHANCER
Foxf1	E-ENHANCER
and	O
the	O
Gli	O
binding	O
on	O
the	O
enhancers	S-ENHANCER
.	O


At	O
first	O
,	O
we	O
found	O
three	B-ENHANCER
evolutionarily	I-ENHANCER
conserved	I-ENHANCER
Foxf1	I-ENHANCER
enhancers	E-ENHANCER
,	O
two	B-ENHANCER
of	I-ENHANCER
which	I-ENHANCER
were	I-ENHANCER
long	I-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	E-ENHANCER
.	O


Of	O
the	O
long	B-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	E-ENHANCER
,	O
one	O
demonstrated	O
tissue	O
-	O
specific	O
activity	O
in	O
the	O
proximal	O
and	O
distal	O
pulmonary	O
blood	O
vessels	O
,	O
while	O
the	O
other	O
one	O
demonstrated	O
activity	O
only	O
in	O
distal	O
blood	O
vessels	O
.	O


At	O
analogous	O
positions	O
in	O
human	O
,	O
these	O
long	B-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	E-ENHANCER
were	O
included	O
in	O
a	O
regulatory	O
region	O
that	O
was	O
reportedly	O
repeatedly	O
deleted	O
in	O
alveolar	O
capillary	O
dysplasia	O
with	O
misalignment	O
of	O
pulmonary	O
vein	O
patients	O
,	O
which	O
indicates	O
the	O
importance	O
of	O
these	O
enhancers	S-ENHANCER
in	O
pulmonary	O
blood	O
vessel	O
formation	O
.	O


We	O
also	O
determined	O
that	O
Gli	O
increased	O
the	O
activity	O
of	O
one	B-ENHANCER
of	I-ENHANCER
these	I-ENHANCER
long	I-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	E-ENHANCER
,	O
which	O
was	O
specific	O
to	O
distal	O
blood	O
vessel	O
,	O
suggesting	O
that	O
Shh	O
regulates	O
Foxf1	O
transcription	O
in	O
pulmonary	O
distal	O
blood	O
vessel	O
formation	O
.	O
